A carregar...
mGlu5, Dopamine D(2) and Adenosine A(2A) Receptors in L-DOPA-induced Dyskinesias
Patients with Parkinson’s disease (PD) receiving L-3,4-dihydroxyphenylalanine (L-DOPA, the gold-standard treatment for this disease) frequently develop abnormal involuntary movements, termed L-DOPA-induced dyskinesias (LID). Glutamate overactivity is well documented in PD and LID. An approach to man...
Na minha lista:
| Publicado no: | Curr Neuropharmacol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Bentham Science Publishers
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4983750/ https://ncbi.nlm.nih.gov/pubmed/26639458 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X14666151201185652 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|